Testosterone therapy for men in 2026 covers more delivery formats, more clinical settings, and more pricing models than it did even three years ago — and the differences between options are clinically significant, not cosmetic.
TL;DR: The best testosterone therapy for men in 2026 depends on delivery format, monitoring protocol, and who manages your care. Weekly intramuscular or subcutaneous injections (testosterone cypionate) remain the clinical standard — lowest cost, most data, tightest titration control. Testosterone pellets suit men who want zero weekly maintenance. Topical gels work but carry transfer risk. The option that fails most men is the one prescribed without a baseline lab panel and a clinician who reads the results. GoodLife Health builds testosterone therapy into a direct primary care membership starting at $179/month.
- Weekly testosterone cypionate injection is the clinical standard: lowest cost ($30–$60/vial), most data, easiest to titrate via day-7 trough draws.
- Testosterone pellets suit men who've already dialed in their dose and want to avoid weekly maintenance — but dosing is locked in for 3–6 months per insertion.
- Topical gels carry a real secondary-transfer risk (up to 2 hours post-application) and an FDA black box warning dating to 2009.
- Oral testosterone (Jatenzo) is the most expensive format and carries a distinct blood-pressure risk signal — 21% of trial participants saw a diastolic increase of ≥10 mmHg.
- The TRAVERSE trial (5,246 men, 33-month median follow-up) found no increase in major cardiovascular events on TRT versus placebo.
- The biggest failure mode isn't the delivery format — it's therapy started without a baseline lab panel or ongoing dose titration.
Why this matters in 2026
About 2.3 million U.S. men received a testosterone prescription in 2022, and that number has grown year over year. The barrier today is not whether a treatment exists — it is whether the person prescribing it ordered the right labs first, and whether they are adjusting your protocol based on what the labs show. A testosterone total of 280 ng/dL means something different in a 35-year-old with low SHBG than it does in a 58-year-old with metabolic syndrome. Delivery format, dose, and follow-up cadence are downstream of that conversation.
The barrier today is not whether a treatment exists — it is whether the person prescribing it ordered the right labs first, and whether they are adjusting your protocol based on what the labs show.
How we ranked
This ranking evaluates the five main testosterone delivery formats available to U.S. men in 2026. Each format is scored on: clinical evidence depth, dosing flexibility, monitoring feasibility, side-effect profile, cost accessibility, and the quality of care model most commonly used to deliver it. Formats requiring no lab follow-up or that are frequently sold through subscription models with no clinician titration are ranked lower, regardless of convenience. The FDA approval status and published pharmacokinetic data for each format are the primary evidence base.
---
The ranked list
1. Testosterone cypionate — weekly injection
Label: The clinical standard
Testosterone cypionate is an FDA-approved, long-acting ester injected intramuscularly or subcutaneously, typically once per week at doses ranging from 50 mg to 200 mg. Peak serum levels occur 24–72 hours post-injection; trough levels are measurable at day 7, which makes titration straightforward — your clinician draws blood on injection day before the shot and sees exactly where you land.
The cost advantage is substantial. Generic testosterone cypionate runs $30–$60 per 10 mL vial at most pharmacies in 2026, enough to last 10–20 weeks at a standard dose. No other format comes close at that price point.
The main clinical risk is erythrocytosis — hematocrit elevation above 54%, which occurs in roughly 3–18% of men on TRT depending on dose and monitoring interval. A clinician who checks a CBC every 6 months catches this before it becomes a problem. Without monitoring, it goes undetected.
Erythrocytosis — hematocrit elevation above 54% — occurs in roughly 3–18% of men on TRT depending on dose and monitoring interval. A CBC every 6 months catches this before it becomes a problem; without monitoring, it goes undetected.
Verdict: Buy. Weekly cypionate is the right starting point for most men. The pharmacokinetics are predictable, the cost is low, and — critically — it gives your clinician the most control over dose adjustments.
---
2. Testosterone enanthate — weekly injection
Label: The interchangeable alternative
Testosterone enanthate is pharmacologically nearly identical to cypionate — same ester length, same injection schedule, same monitoring protocol. The half-life is 4.5 days versus cypionate's 8 days, which means slightly faster peak and faster trough, but the clinical difference in a weekly protocol is small enough that most men will not notice it.
Enanthate is the dominant format in Europe and is sometimes more readily available at certain compounding pharmacies in the U.S. in 2026. Dosing ranges mirror cypionate: 50–200 mg weekly.
If your pharmacy runs out of cypionate — which happened intermittently in 2023 and 2024 — enanthate is a direct substitute with no protocol change required.
Verdict: Buy. Use cypionate first; switch to enanthate if supply or cost dictates. Do not change your monitoring schedule when you switch.
---
3. Testosterone pellets — subcutaneous implant
Label: The set-it-and-forget-it option
Pellets (brand: Testopel; also available through compounding pharmacies) are implanted subcutaneously in the upper buttock in a 10-minute in-office procedure. Each pellet contains 75 mg of testosterone and dissolves over 3–6 months. A typical protocol involves 6–12 pellets per insertion, delivering roughly 450–900 mg total over the reabsorption period.
The pharmacokinetic profile is more stable than weekly injections — no peak-trough swing — and compliance is near-perfect because there is nothing to remember between insertions. For men who travel frequently or find weekly injections difficult to maintain, pellets solve a real logistics problem.
The downside is irreversibility within the implant cycle. If your clinician over-doses at insertion, you cannot reduce the dose — you wait for the pellets to dissolve. In 2026, a testosterone pellet dosing for men protocol from a clinician who adjusts insertion dose based on previous cycle labs reduces this risk materially.
Cost is higher than injections: procedure fees run $300–$600 per insertion at most clinics, plus the cost of the pellets themselves.
Verdict: Buy — with the right clinician. Pellets work well for men who have already established their optimal dose on injections and want to reduce management burden. Starting on pellets without a dose baseline is a clinical mistake.
---
4. Testosterone gels and creams — topical
Label: The convenience option with a caveat
FDA-approved topical testosterone (AndroGel, Testim, Axiron, and compounded creams) delivers testosterone transdermally, applied daily to the shoulders, upper arms, or inner thighs. Absorption varies by application site, skin thickness, and whether the area is washed before application — which introduces more inter-patient and intra-patient variability than injections.
The clinical concern that gets underreported: secondary transfer. Testosterone gel can transfer to partners and children through skin contact for up to 2 hours after application. The FDA added a black box warning on this in 2009, and it remains relevant in 2026. Men with children under 12 in the household need to be counseled on washing and covering the application site.
Gels are more expensive than injections when paid out-of-pocket — branded versions can run $200–$400/month without insurance — though compounded creams through a DPC practice like GoodLife Health bring costs down significantly.
Verdict: Hold. Gels are a reasonable option for men with needle aversion or who cannot tolerate injections, but the transfer risk and absorption variability make them a second-line choice for most.
---
5. Oral testosterone — undecanoate
Label: The newcomer, not yet best-in-class
Jatenzo (testosterone undecanoate) received FDA approval in 2019 and is the first oral testosterone cleared in the U.S. in decades. It must be taken twice daily with food (specifically a meal containing fat ≥15 g) to achieve adequate absorption via the lymphatic route. Miss a meal, take it with the wrong food, or forget the evening dose and your levels drop.
The cardiovascular signal is worth noting: Jatenzo carries an FDA warning for blood pressure increases. In the pivotal trial, 21% of men experienced a diastolic BP increase of ≥10 mmHg. For men who are already managing hypertension, that is a meaningful risk that injectable formats do not carry to the same degree.
Retail cost in 2026 runs approximately $500–$800/month without insurance, making it the most expensive format on this list by a wide margin.
Verdict: Wait. Oral testosterone is appropriate for a specific patient — needle aversion, cannot tolerate topicals, normotensive baseline — but it is not the right first choice for most men, and the price point is not justified by the clinical outcomes relative to injectable cypionate.
---
Comparison table
Testosterone delivery format comparison
2026 pricing and monitoring
| Format | Dosing Frequency | Avg. Monthly Cost (2026) | Level Stability | FDA Approval | Monitoring Complexity |
|---|---|---|---|---|---|
| Testosterone cypionate (injection) | Weekly | $30–$60 | Moderate (trough predictable) | Yes | Low |
| Testosterone enanthate (injection) | Weekly | $40–$70 | Moderate | Yes | Low |
| Testosterone pellets | Every 3–6 months | $300–$600/insertion | High | Yes (Testopel) | Moderate |
| Topical gels/creams | Daily | $50–$400 | Low–Moderate | Yes | Moderate |
| Oral undecanoate (Jatenzo) | Twice daily | $500–$800 | Moderate | Yes | High |
---
What to avoid
Testosterone prescribed without a baseline lab panel. Total testosterone, free testosterone, SHBG, LH, FSH, hematocrit, PSA, and a basic metabolic panel are the minimum before starting. A prescription written on symptoms alone — without knowing where your labs sit — cannot be titrated correctly. Any service that skips this step is prescribing blind.
"Low-T" clinics that do not monitor estradiol. Testosterone aromatizes to estradiol. Men on TRT who develop high estradiol (above 40–50 pg/mL by sensitive assay) experience symptoms that look identical to low testosterone — fatigue, mood instability, water retention — and are sometimes incorrectly told to raise their dose. A clinician who does not check estradiol at each monitoring visit is missing half the picture.
Testosterone aromatizes to estradiol. Men who develop high estradiol (above 40–50 pg/mL by sensitive assay) can present with fatigue, mood instability, and water retention — symptoms that mimic low testosterone and are sometimes incorrectly treated by raising the dose instead of checking estradiol.
Subscription testosterone services with no dose titration. Several direct-to-consumer platforms in 2026 offer a flat dose shipped monthly. The problem: 100 mg/week of testosterone cypionate produces serum levels anywhere from 500 to 1,200 ng/dL depending on the individual's metabolism. Without a follow-up trough draw and dose adjustment, you are guessing. The low testosterone symptoms in men — what labs actually show guide at GoodLife Health covers exactly what a proper monitoring panel looks like.
---
Where to get the best testosterone therapy for men in 2026
Direct primary care practices — GoodLife Health memberships start at $179/month and include testosterone therapy management with lab ordering, result review, and protocol adjustment by a licensed clinician. The membership model means your clinician's incentive is your outcomes, not a per-visit billing code.
Urology and endocrinology offices — Appropriate for men with comorbidities (prior prostate cancer history, complex hypogonadism secondary to pituitary pathology). Expect longer wait times and higher per-visit costs under traditional insurance billing.
Compounding pharmacies with prescribing clinicians — Useful for men who need non-standard doses or formats (e.g., subcutaneous testosterone cypionate at 40 mg twice weekly for more stable levels). Requires a prescribing relationship with someone who monitors labs.
---
FAQ
What is the best testosterone therapy for men in 2026? Weekly testosterone cypionate injection is the best starting option for most men — lowest cost, most published data, easiest to titrate, and a predictable trough that tells your clinician exactly where your levels land before the next dose.
How long does it take for testosterone therapy to work? Most men notice energy and libido changes within 3–6 weeks of reaching a therapeutic serum level (typically 500–900 ng/dL total testosterone). Body composition changes — increased lean mass, reduced fat mass — take 3–6 months of consistent dosing and adequate protein intake.
Is testosterone therapy safe long-term? The published data on long-term TRT safety improved significantly with the TRAVERSE trial (2023), which followed 5,246 men with hypogonadism for a median of 33 months and found no increase in major adverse cardiovascular events versus placebo. Erythrocytosis and sleep apnea remain the primary monitored risks.
What labs are needed before starting testosterone therapy? Minimum: total testosterone (morning draw, fasting preferred), free testosterone, SHBG, LH, FSH, hematocrit/CBC, PSA (men over 40), comprehensive metabolic panel, estradiol (sensitive assay). Some clinicians also check DHEA-S and thyroid panel at baseline.
How much does testosterone therapy cost per month? Injectable cypionate alone costs $30–$60/month. The real cost is the care model around it — lab monitoring, clinician time, dose adjustments. A DPC membership like GoodLife Health bundles all of that for $179/month, which is less than two urgent care visits under most insurance plans.
Is testosterone therapy covered by insurance? FDA-approved testosterone is covered by most insurance plans when hypogonadism is diagnosed (ICD-10: E29.1). Out-of-pocket cost through a DPC membership is often lower than the copay stack under traditional insurance once labs and office visits are factored in.
What is the difference between pellets and injections for testosterone? Injections give your clinician more titration control — you can adjust dose weekly. Pellets offer better compliance and more stable levels but lock in the dose for 3–6 months per insertion. See how hormone pellet therapy compares to injections for a detailed breakdown.
Can testosterone therapy affect fertility? Yes. Exogenous testosterone suppresses LH and FSH, which reduces or eliminates sperm production in most men. Men who want to preserve fertility should discuss clomiphene citrate or hCG protocols with their clinician before starting TRT.
---
One last thing
The TRAVERSE trial — the largest randomized controlled trial of testosterone therapy in cardiovascular-risk men ever conducted — found that TRT did not increase heart attack or stroke risk over 33 months. That data, published in the New England Journal of Medicine in 2023, cleared the single biggest clinical question that had kept cautious physicians from prescribing TRT for a decade. The conversation in 2026 has shifted from "is it safe" to "is the monitoring good enough." That second question is the one worth asking your clinician.
---
Related guides
- Low testosterone symptoms in men — what labs actually show
- Testosterone pellet dosing for men — what to expect
- How hormone pellet therapy compares to injections
- How to optimize hormones for energy and mood
References
- Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. 2018. doi.org/10.1210/jc.2018-00229